American Association for the Advancement of Science, Science Translational Medicine, 526(12), 2020
DOI: 10.1126/scitranslmed.aax9340
Full text: Unavailable
Inhibition of stromal cell PKC-β mitigates environment-mediated drug resistance in B cell malignancies.